Osteoarthritis Trial, Recruiting NCT07405983 Sponsor: Keri Medical SA Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07405983
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who need their first joint replacement surgery at the base of the thumb (the joint where the thumb meets the wrist) to treat a specific stage of arthritis in that joint (Eaton-Littler Stage II or III — confirm with trial site what stage applies)
  • People who are 22 years of age or older at the time of joining the trial
  • People who are willing and able to sign a consent form agreeing to take part in the study

Who may not be able to join:

  • People who have an active or ongoing infection, whether in a specific part of the body or throughout the whole body
  • People who have severe muscle, nerve, or blood vessel problems that affect the thumb joint
  • People whose bones are not strong or large enough to properly hold the replacement joint implant in place
  • People whose bone size is not compatible with the available implant sizes
  • People who have a known allergy to the materials used in the replacement joint device
  • People who have another condition that could affect how well the replacement joint works, such as arthritis in the wrist
  • People under 22 years of age whose bones are still growing
  • People who are pregnant or breastfeeding
  • People who have a medical condition that makes surgery in general unsafe for them
  • People who have an intellectual disability that would prevent them from following their surgeon's instructions during recovery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41 58 611 0062

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Keri Medical SA
Registry
ClinicalTrials.gov
Start date
4 March 2026
Est. completion
1 November 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinical Composite Success

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov